Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P G Parsons

Showing results (91-100 of 136) with videos related to

Pageof 14
Sort By:
International Journal of Cancer|July 15, 1994
A nonconsensus octamer-recognition sequence (TAATGARAT-motif) identifies a novel DNA binding protein in human Merkel cell carcinoma cell linesJ A Thomson, J H Leonard, K McGregor, et al.
Redox Report : Communications in Free Radical Research|April 20, 2000
Transcriptional responses of human melanocytes to solar UVG M Boyle, A J Bodero, J Pedley, et al.
Melanoma Research|March 21, 1998
Redox regulation of Brn-2/N-Oct-3 POU domain DNA binding activity and proteolytic formation of N-Oct-5 during melanoma cell nuclear extractionA G Smith, G Brightwell, S E Smit, et al.
Biochemistry|September 2, 1997
Mechanism of action of fotemustine, a new chloroethylnitrosourea anticancer agent: evidence for the formation of two DNA-reactive intermediates contributing to cytotoxicityM T Hayes, J Bartley, P G Parsons, et al.
European Journal of Biochemistry|October 13, 2000
Domains of Brn-2 that mediate homodimerization and interaction with general and melanocytic transcription factorsD J Smit, A G Smith, P G Parsons, et al.
Molecular Biology of the Cell|June 10, 2000
Histone deacetylase inhibitors trigger a G2 checkpoint in normal cells that is defective in tumor cellsL Qiu, A Burgess, D P Fairlie, et al.
Virchows Archiv. A, Pathological Anatomy and Histopathology|January 1, 1990
Complementary expression of melanosomal antigens and constant expression of pigment-independent antigen during the evolution of melanocytic tumoursH Takahashi, P G Parsons, D Favier, et al.
Pigment Cell Research|August 1, 1994
Expression studies of pigmentation and POU-domain genes in human melanoma cellsR A Sturm, B J O'Sullivan, J A Thomson, et al.
British Journal of Cancer|June 22, 1999
Anti-tumour activity in vitro and in vivo of selective differentiating agents containing hydroxamateL Qiu, M J Kelso, C Hansen, et al.
International Journal for Parasitology|June 17, 2000
Anti-malarial effect of histone deacetylation inhibitors and mammalian tumour cytodifferentiating agentsK T Andrews, A Walduck, M J Kelso, et al.
Pageof 14

Showing results (91-100 of 136) with videos related to

Sort By:
Pageof 14
International Journal of Cancer|July 15, 1994
A nonconsensus octamer-recognition sequence (TAATGARAT-motif) identifies a novel DNA binding protein in human Merkel cell carcinoma cell linesJ A Thomson, J H Leonard, K McGregor, et al.
Redox Report : Communications in Free Radical Research|April 20, 2000
Transcriptional responses of human melanocytes to solar UVG M Boyle, A J Bodero, J Pedley, et al.
Melanoma Research|March 21, 1998
Redox regulation of Brn-2/N-Oct-3 POU domain DNA binding activity and proteolytic formation of N-Oct-5 during melanoma cell nuclear extractionA G Smith, G Brightwell, S E Smit, et al.
Biochemistry|September 2, 1997
Mechanism of action of fotemustine, a new chloroethylnitrosourea anticancer agent: evidence for the formation of two DNA-reactive intermediates contributing to cytotoxicityM T Hayes, J Bartley, P G Parsons, et al.
European Journal of Biochemistry|October 13, 2000
Domains of Brn-2 that mediate homodimerization and interaction with general and melanocytic transcription factorsD J Smit, A G Smith, P G Parsons, et al.
Molecular Biology of the Cell|June 10, 2000
Histone deacetylase inhibitors trigger a G2 checkpoint in normal cells that is defective in tumor cellsL Qiu, A Burgess, D P Fairlie, et al.
Virchows Archiv. A, Pathological Anatomy and Histopathology|January 1, 1990
Complementary expression of melanosomal antigens and constant expression of pigment-independent antigen during the evolution of melanocytic tumoursH Takahashi, P G Parsons, D Favier, et al.
Pigment Cell Research|August 1, 1994
Expression studies of pigmentation and POU-domain genes in human melanoma cellsR A Sturm, B J O'Sullivan, J A Thomson, et al.
British Journal of Cancer|June 22, 1999
Anti-tumour activity in vitro and in vivo of selective differentiating agents containing hydroxamateL Qiu, M J Kelso, C Hansen, et al.
International Journal for Parasitology|June 17, 2000
Anti-malarial effect of histone deacetylation inhibitors and mammalian tumour cytodifferentiating agentsK T Andrews, A Walduck, M J Kelso, et al.
Pageof 14